Nomenclature
CAS number: 55-94-7
2,2′-[(1,4-Dioxo-1,4-butanediyl)bis(oxy)]bis[
N,N,N-trimethylethanaminium] dibromide; bis[2-dimethylaminoethyl]succinate bis[methobromide]; 3,8-dioxadecane-4,7-dione-1,10-bis[trimethylammonium bromide]; suxamethonium bromide; IS-370; compd 48/268; LT-1; M & B 2207; Brevidil M (M & B).
C
14H
30Br
2N
2O
4; mol wt 450.21.
C 37.35%, H 6.72%, Br 35.50%, N 6.22%, O 14.22%.
Description and references
Prepd by reacting β-bromoethyl succinate with
trimethylamine: Glick, J. Biol. Chem. 137, 357 (1941); Fusco et al., Gazz. Chim. Ital. 79, 129, 837
(1949); Walker, J. Chem. Soc. 1950, 193. Alternate prepns: Phillips, J. Am. Chem. Soc. 71, 3264 (1949); Tammelin, Acta Chem. Scand. 7, 185 (1953).
Properties
Slightly hygroscopic crystals, mp 225°. Freely sol in water or
normal saline, giving solns which are very slightly acidic. Aq solns
undergo progressive hydrolysis with corresponding loss of activity
and increase in acidity. Prepare solns just
before using. The rate of this decompn increases with
temp and autoclaving or prolonged exposure to warmth should be avoided.Therapeutic Category
Neuromuscular blocking agent.
Keywords
Neuromuscular Blocking Agent; Depolarizing Agents